Prognostic and predictive role of proliferation indices in adjuvant therapy of breast cancer.

Daidone, M G; Silvestrini, R

Daidone, M G; Silvestrini, R.

Affiliation

Daidone MG; Department of Experimental Oncology, Istituto Nazionale per lo Studio e la Cura dei Tumori, Via Venezian, 1, 20133 Milan, Italy. daidone@istitutotumori.mi.it

J Natl Cancer Inst Monogr ; (30): 27-35, 2001.

Article in En | MEDLINE | ID: mdl-11773289

Subject(s)

Antineoplastic Agents/therapeutic use; Breast Neoplasms/diagnosis; Breast Neoplasms/drug therapy; Chemotherapy, Adjuvant/statistics & numerical data; Breast Neoplasms/pathology; Cell Division; Humans; Lymphatic Metastasis; Predictive Value of Tests; Prognosis; Recurrence; Risk Factors

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Chemotherapy, Adjuvant / Antineoplastic Agents Type of study: Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: J Natl Cancer Inst Monogr Journal subject: NEOPLASIAS Year: 2001 Document type: Article Affiliation country: Italy Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links